A Study of TFX05-01 in Patients With Advanced Solid Tumors
Clinical trial NCT05434299 · UNKNOWN
Trial details
- NCT number
- NCT05434299
- Sponsor
- Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-05
- Primary completion
- 2024-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.